TIENAM 500 mg/500 mg, powder for solution for infusion bottle
Active ingredients: Cilastatin, Cilastatin sodium, IMIPÉNEM ANHYDRE, Imipenem hydrate
Commercialized according to BDPMDispensing in France: Prescription only
Powder for solution for infusionbottleintraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- TIENAM 500 mg/500 mg, poudre pour solution pour perfusion
- Pharmaceutical form
- poudre pour solution pour perfusion
- Route of administration
- intraveineuse
- Presentation description
- 1 flacon(s) en verre
- Marketing authorisation holder
- MSD FRANCE
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 30 Oct 2024
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Prescribed by a hospital doctor
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
69552232CIP73833700CIP133400938337006Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| IMIPÉNEM MONOHYDRATÉpoudre | — | SA |
| CILASTATINE SODIQUEpoudre | — | SA |
| IMIPÉNEM ANHYDREpoudre | 500 mg · un flacon | FT |
| CILASTATINE ANHYDREpoudre | 500 mg · un flacon | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.